Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 7 | 18 | 30 | 15 | 70 |
Essential hypertension | D000075222 | — | I10 | — | 1 | 24 | 6 | 3 | 34 |
Healthy volunteers/patients | — | — | — | 16 | — | 1 | 1 | — | 18 |
Dyslipidemias | D050171 | HP_0003119 | — | — | — | 2 | 2 | 2 | 6 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 3 | 2 | — | 5 |
Covid-19 | D000086382 | — | U07.1 | — | — | 1 | 2 | 1 | 4 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | 1 | 3 | — | 4 |
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 2 | 1 | 3 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | 2 | 1 | — | 3 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | 2 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 1 | 2 | — | — | 3 |
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | — | — | 1 | — | 1 | 2 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | 2 | — | — | 2 |
Proteinuria | D011507 | HP_0000093 | R80 | — | — | 2 | — | — | 2 |
Pneumonia | D011014 | EFO_0003106 | — | — | — | 1 | — | — | 1 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | — | 1 | — | — | 1 |
Isolated systolic hypertension | D000092244 | — | — | — | — | 1 | — | — | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 1 | — | — | 1 |
Retinal diseases | D012164 | HP_0000479 | H35.9 | — | — | 1 | — | — | 1 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ischemic stroke | D000083242 | — | — | — | 2 | — | — | — | 2 |
Coronary disease | D003327 | — | — | — | 1 | — | — | — | 1 |
Glomerulonephritis | D005921 | HP_0000099 | N05 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Therapeutic equivalency | D013810 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | — | — | 1 | 1 |
Frailty | D000073496 | — | R53.1 | — | — | — | — | 1 | 1 |
Hyperaldosteronism | D006929 | HP_0011736 | E26 | — | — | — | — | 1 | 1 |
Ambulatory blood pressure monitoring | D018660 | — | — | — | — | — | — | 1 | 1 |
Vascular stiffness | D059289 | — | — | — | — | — | — | 1 | 1 |
Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 1 | 1 |
Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | — | — | — | — | 1 | 1 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | — | — | — | — | 1 | 1 |
Glucose intolerance | D018149 | HP_0000833 | R73.03 | — | — | — | — | 1 | 1 |
Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 1 | 1 |